DCTH ▲ +2.1% - Delcath Systems, Inc.
$DCTH Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
19-OCT-2026 04:01 PM ET
Share this post
More filings for $DCTH
DCTH - Delcath Systems, Inc. - SEC Filing Update (19-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 19, 2026$DCTH SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026
View full $DCTH filing history →💬 Comments
Loading comments…
Leave a comment